Latest News about LLY
Recent news which mentions LLY
From MarketWatch
From Benzinga
RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today
February 24, 2021
From InvestorPlace
Veru Files US Application For TADFIN Combo For Prostate Enlargement
February 23, 2021
From Benzinga
Should You Follow Cathie Wood Into This Coronavirus Stock?
February 23, 2021
From Motley Fool
3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
February 21, 2021
From Motley Fool
Precision Bio's ARCUS Gene Editing Platform Is Safe, Durable; Long-Term Animal Study Shows
February 19, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
February 19, 2021
From Benzinga
RIGL Stock: Why Rigel Pharmaceuticals Is Climbing Today
February 18, 2021
From InvestorPlace
Why Rigel Pharmaceuticals Stock Is Jumping Today
February 18, 2021
From Motley Fool
Lilly Strikes Licensing Deal With Rigel In Push Toward Neurological, Immunological Therapies
February 18, 2021
From Benzinga
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
February 18, 2021
From Benzinga
Dow futures retreat ahead of weekly jobless claims report
February 18, 2021
From MarketWatch
Eli Lilly's Tirzepatide Reduces A1C And Body Weight, Late-Stage Studies In Type 2 Diabetes Show
February 17, 2021
Tickers
LLY
From Benzinga
Can Coronavirus Antibodies Overcome Their Obstacles?
February 12, 2021
From Motley Fool
Could Cassava Sciences Be a Millionaire-Maker Stock?
February 11, 2021
From Motley Fool
ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today
February 11, 2021
From InvestorPlace
4 Top COVID Stocks to Buy in February
February 11, 2021
From Motley Fool
How Risky Are These Heavily Shorted COVID Stocks?
February 11, 2021
From Motley Fool
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
February 11, 2021
From Motley Fool
Eli Lilly Doesn't Plan To Claw Back Past Pay From Former CFO - WSJ
February 10, 2021
Tickers
LLY
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
From Benzinga
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
February 10, 2021
From Benzinga
What's Behind Incyte's Better-Than-Expected Q4 Earnings
February 09, 2021
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.